Robin Farias-Eisner

No ORCID on file · 6 papers in corpus
meta-analysis 2026
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2026.06.015

OBJECTIVE: This study quantifies serum/plasma interleukin-6 levels across the healthy-nonendometriosis, benign-endometriosis-ovarian cancer spectrum, focusing on pooled geometric means stratified by control type. DATA SOURCES: PubMed (MEDL…

lab-animal 2020
Journal of cancer research and therapeutic oncology ·doi:10.17303/jcrto.2020.8.101

A growing body of literature supports the role of apolipoproteins present in HDL in the treatment of pro-inflammatory diseases including cancer. We examined whether bovine HDL (bHDL) and three dual-domain peptides, namely AEM-28 and its ana…

other 2020
Journal of cancer research and therapeutic oncology ·doi:10.17303/jcrto.2020.8.206

BACKGROUND: Endometriosis is complex, but identifying the novel biomarkers, inflammatory molecules, and genetic links holds the key to the enhanced detection, prediction and treatment of both endometriosis and endometriosis related malignan…

review 2019
Journal of cancer metastasis and treatment ·doi:10.20517/2394-4722.2018.25

Ovarian cancer (OC) is a serious condition that often presents at advanced stages and has high mortality rates, with the current mode of early-stage screening lacking sensitivity and specificity. OC often presents asymptomatically, which re…

other 2016
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2015.12.012
review 2014
World journal of biological chemistry ·doi:10.4331/wjbc.v5.i3.286

Ovarian cancer is a lethal gynecologic malignancy with greater than 70% of women presenting with advanced stage disease. Despite new treatments, long term outcomes have not significantly changed in the past 30 years with the five-year overa…